Financial Wire

Apple's Fiscal Q2 Earnings Could Beat Street Consensus, BofA Says

-- Apple's (AAPL) fiscal Q2 earnings could exceed Street estimates on strong iPhone sales, double-digit growth in Services revenue and foreign-exchange tailwinds, BofA Securities said Tuesday in a note.

Upcoming catalysts include a new buyback authorization, the Worldwide Developers Conference in June, the launch of a foldable iPhone in the fall, and the launch of an enhanced Siri integrated with Gemini AI, according to the note.

The brokerage said it expects strong iPhone demand and raised its iPhone unit estimate for fiscal Q2 to 60 million. It models 14% revenue growth for Services, in line with management's guidance.

BofA models fiscal Q2 revenue and earnings per share of $113 billion and $2, respectively, versus Street consensus of $109 billion and $1.93.

The brokerage expects fiscal Q3 revenue and EPS of $106 billion and $1.82, compared with Street consensus of $103 billion and $1.74, respectively.

It also raised its fiscal 2026 revenue and EPS estimates to $466 billion and $8.55 from $462 billion and $8.36.

Apple is scheduled to report fiscal Q2 results on April 30.

BofA maintained a Buy rating on Apple and raised its price target to $325 from $320.

Price: $259.25, Change: $+0.05, Percent Change: +0.02%

相关文章

Treasury

恩智浦半导体赎回7.5亿美元2026年到期高级票据

恩智浦半导体(NXPI)周一晚间表示,其子公司恩智浦(NXP)连同恩智浦美国公司(NXP USA)和恩智浦融资公司(NXP Funding)已根据适用契约的条款赎回了7.5亿美元未偿还的、票面利率为3.875%、将于2026年6月到期的优先票据。

$NXPI
Insider Trading

根据最近提交给美国证券交易委员会(SEC)的文件显示,Hims & Hers Health 的一位内部人士出售了价值 1,457,305 美元的股票。

首席财务官奥卢耶米·奥库佩 (Oluyemi Okupe) 于 2026 年 4 月 16 日出售了 Hims & Hers Health (HIMS) 的 54,927 股股票,套现 1,457,305 美元。根据向美国证券交易委员会 (SEC) 提交的 4 号表格文件,奥库佩目前控制着该公司共计 277,899 股 A 类普通股,其中 270,046 股为直接持有,7,853 股为间接控制。 SEC 文件链接: https://www.sec.gov/Archives/edgar/data/1773751/000190705626000014/xslF345X05/wk-form4_1776717480.xml

$HIMS
Insider Trading

根据最近提交给美国证券交易委员会(SEC)的文件显示,联合治疗公司(United Therapeutics)内部人士出售了价值5,573,223美元的股票。

2026年4月17日,董事、董事长兼首席执行官Martine A Rothblatt出售了其持有的United Therapeutics (UTHR) 9,500股股票,套现5,573,223美元。根据向美国证券交易委员会(SEC)提交的4号表格文件,Rothblatt目前控制着该公司共计679,797股普通股,其中直接持有40,513股,间接控制639,284股。 SEC文件链接: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000035/xslF345X05/primarydocument.xml

$UTHR